首頁 > 市場調查報告書 > 醫療設備

體外診斷癌症

2030 年亞太地區肺癌篩檢市場預測 - 區域分析 - 按癌症類型、技術、年齡層（50 歲及以上和 50 歲以下）和最終用戶（醫院、診斷中心等）

市場調查報告書

商品編碼

1402525

2030 年亞太地區肺癌篩檢市場預測 - 區域分析 - 按癌症類型、技術、年齡層（50 歲及以上和 50 歲以下）和最終用戶（醫院、診斷中心等）

Asia Pacific Lung Cancer Screening Market Forecast to 2030 - Regional Analysis - by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

出版日期: 2023年11月01日 | 出版商:

The Insight Partners | 英文 132 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

亞太地區肺癌篩檢市場預計將從2022年的7.112億美元成長到2030年的13.6243億美元。預計2022年至2030年CAGR為8.5%。

結構化肺癌篩檢計畫推動亞太肺癌篩檢市場

一些國家面臨肺癌篩檢計畫的挑戰。以人口為基礎的澳洲篩檢計畫的一些例子包括「BreastScreen」、「國家腸癌篩檢計畫」和「全國子宮頸篩檢計畫」。

RIVM 人口篩檢中心 (RIVM-CvB) 代表衛生部領導和管理國家人口篩檢計畫；根據該計劃，所有荷蘭公民都被邀請在生命中的某個階段參加國家篩檢計劃。紐約州啟動、設立並資助三個癌症族群篩檢計畫。

因此，對結構良好的計劃至關重要，例如社區為基礎的計劃或臨床醫生和潛在參與者之間共享的、知情的決策計劃；經認可的報告中心；以及用於品質控制、監測和結果報告的中央資料登記處。此外，綜合戒菸干預、支持成本效益的國際資料、額外的死亡率福利和高永續性率是肺癌篩檢必須研究的幾個因素。此外，國際肺癌研究協會建議在不參與肺癌篩檢研究的亞太國家實施可行性篩檢計畫。這些計劃包括戒菸措施、用於選擇和管理篩選參與者的標準化演算法，以及管理具有積極篩檢結果的參與者的專業多學科團隊。因此，在預測期內，實施結構化肺癌篩檢計畫預計將成為肺癌篩檢市場的一個利潤豐厚的機會。

亞太地區肺癌篩檢市場概況

亞太地區肺癌篩檢市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。該地區的成長歸因於多種因素，例如肺癌發病率的增加和人們吸煙率的增加。此外，政府對篩檢的支持不斷增加，導致市場進一步成長。

亞太地區肺癌篩檢市場2030年營收及預測（百萬美元）

亞太地區肺癌篩檢市場細分

亞太地區肺癌篩檢市場按癌症類型、技術、年齡層、最終用戶和國家細分。

根據癌症類型，亞太地區肺癌篩檢市場分為非小細胞肺癌（NSCLC）和小細胞肺癌。 2022年，非小細胞肺癌（NSCLC）細分市場在亞太地區肺癌篩檢市場中佔據更大佔有率。

根據技術，亞太地區肺癌篩檢市場分為胸部X光檢查、低劑量電腦斷層掃描（LDCT）、液體切片等。 2022年，胸部X光檢查在亞太地區肺癌篩檢市場中佔據最大佔有率。

根據年齡層，亞太地區肺癌篩檢市場分為50歲及以上及50歲以下。2022年，50歲及以上細分市場在亞太地區肺癌篩檢市場中佔有較大佔有率。

根據最終用戶，亞太地區肺癌篩檢市場分為醫院、診斷中心等。 2022年，醫院細分市場在亞太地區肺癌篩檢市場中佔據最大佔有率。

依國家分類，亞太地區肺癌篩檢市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2022年，中國在亞太地區肺癌篩檢市場佔據主導地位。

Intelerad Medical Systems Incorporated、Nuance Communications Inc、GE HealthCare Technologies Inc、Medtronic Plc、佳能醫療系統公司、皇家飛利浦 NV 和西門子 AG 是亞太地區肺癌篩檢市場上的一些領先公司。

研究範圍
Insight Partners 研究報告指南
市場區隔
- 亞太地區肺癌篩檢市場 - 按技術分類
- 亞太地區肺癌篩檢市場 - 按癌症類型
- 亞太地區肺癌篩檢市場 - 按年齡層
- 亞太地區肺癌篩檢市場 - 按最終用戶分類
- 亞太地區肺癌篩檢市場 - 按國家/地區

第 2 章：亞太地區肺癌篩檢市場 - 要點

第 3 章：研究方法

覆蓋範圍
二次研究
初步研究

第 4 章：亞太地區肺癌篩檢市場 - 市場格局

概述
亞太地區 PEST 分析
專家意見

第 5 章：亞太地區肺癌篩檢市場 - 主要市場動態

市場促進因素
- 肺癌發生率上升
- 增加政府支持
市場限制
- 肺癌篩檢測試成本高昂
市場機會
- 結構化肺癌篩檢計劃
未來的趨勢
- 移動式肺癌篩檢車
影響分析

第 6 章：亞太地區肺癌篩檢市場 - 亞太地區分析

亞太地區肺癌篩檢市場收入預測與分析

第 7 章：亞太地區肺癌篩檢市場 - 2028 年收入和預測 - 按癌症類型

概述
2022 年及 2030 年亞太地區肺癌篩檢市場收入佔有率，依癌症類型分類（%）
非小細胞肺癌 (NSCLC)
小細胞肺癌

第 8 章：亞太地區肺癌篩檢市場分析 - 按技術

概述
低劑量電腦斷層掃描 (LDCT)
胸部X光檢查
液體活體組織切片
其他

第 9 章：亞太地區肺癌篩檢市場分析 - 按年齡層

概述
及較舊的
50以下

第 10 章：亞太地區肺癌篩檢市場分析 - 按最終用戶

概述
醫院
診斷中心
其他

第 11 章：亞太地區肺癌篩檢市場 - 收入和 2028 年預測 - 國家分析

亞太肺癌篩檢市場

第 12 章：亞太地區肺癌篩檢市場-產業格局

近期成長策略
- 概述

第 13 章：公司簡介

Intelerad Medical Systems
Nuance Communications Inc
GE HealthCare
Medtronic
Canon Inc.
Koninklijke Philips NV
Siemens AG

第 14 章：附錄

關於 Insight Partners
專業術語

簡介目錄圖表

Product Code: BMIRE00029045

The Asia Pacific lung cancer screening market is expected to grow from US$ 711.20 million in 2022 to US$ 1,362.43 million by 2030. It is estimated to grow at a CAGR of 8.5% from 2022 to 2030.

Structured Lung Cancer Screening Program Fuel Asia Pacific lung Cancer Screening Market

Several countries face challenges with lung cancer screening programs. A few examples of population-based Australian screening programs are "BreastScreen," the "National Bowel Cancer Screening Program," and the "National Cervical Screening Program."

On behalf of the Ministry of Health, the RIVM Center for Population Screening (RIVM-CvB) leads and manages the National Population Screening Programme; under which all Dutch citizens are invited, at a certain point in their lives, to participate in one of the national screening programs. The State begins, sets up, and finances three cancer population screening programs.

Therefore, there is a crucial requirement for a well-structured program such as a community-based program or a shared, informed decision-making program between clinicians and potential participants; accredited reporting centers; and a central data registry for quality control, monitoring, and outcome reporting. Additionally, integrated smoking cessation intervention, international data supporting cost-effectiveness, additional mortality benefits, and a high sustainability rate are a few factors that must be studied for lung cancer screening. Further, the International Association for the Study of Lung Cancer recommends implementing feasibility screening programs in the countries of Asia Pacific without participating in lung cancer screening studies. These programs involve smoking cessation initiatives, standardized algorithms for selecting and managing screening participants, and specialist multidisciplinary teams to manage participants with positive screening results. Therefore, the implementation of structured lung cancer screening programs is expected to be a lucrative opportunity in the lung cancer screening market during the forecast period.

Asia Pacific Lung Cancer Screening Market Overview

The Asia Pacific lung cancer screening market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The regional growth is attributed to various factors, such as the increasing incidence of lung cancer and growing prevalence of cigarette smoking among people. Also, rising government support for screening has led to the further growth of the market.

Asia Pacific lung cancer screening market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Lung Cancer Screening Market Segmentation

The Asia Pacific lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the Asia Pacific lung cancer screening market is segmented into Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer. The non-small cell lung cancer (NSCLC) segment held a larger share of the Asia Pacific lung cancer screening market in 2022.

Based on technology, the Asia Pacific lung cancer screening market is segmented into chest x-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest x-ray segment held the largest share of the Asia Pacific lung cancer screening market in 2022.

Based on age group, the Asia Pacific lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the Asia Pacific lung cancer screening market in 2022.

Based on end user, the Asia Pacific lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the Asia Pacific lung cancer screening market in 2022.

Based on country, the Asia Pacific Lung Cancer Screening Market is segmented into China Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific lung cancer screening market in 2022.

Intelerad Medical Systems Incorporated, Nuance Communications Inc, GE HealthCare Technologies Inc, Medtronic Plc, Canon Medical Systems Corp, Koninklijke Philips NV, and Siemens AG are some of the leading companies operating in the Asia Pacific lung cancer screening market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Lung Cancer Screening Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Lung Cancer Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Asia Pacific Lung Cancer Screening Market - by Technology
- 1.3.2 Asia Pacific Lung Cancer Screening Market - by Cancer Type
- 1.3.3 Asia Pacific Lung Cancer Screening Market - by Age Group
- 1.3.4 Asia Pacific Lung Cancer Screening Market - by End User
- 1.3.5 Asia Pacific Lung Cancer Screening Market - by Country

2. Asia Pacific Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Lung Cancer Screening Market - Market Landscape

4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert's Opinion

5. Asia Pacific Lung Cancer Screening Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Lung Cancer Incidences
- 5.1.2 Increasing Government Support
5.2 Market Restraints
- 5.2.1 High Cost of Lung Cancer Screening Tests
5.3 Market Opportunities
- 5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
- 5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis

6. Asia Pacific Lung Cancer Screening Market - Asia Pacific Analysis

6.1 Asia Pacific Lung Cancer Screening Market Revenue Forecast and Analysis

7. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

7.1 Overview
7.2 Asia Pacific Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non-Small Cell Lung Cancer (NSCLC)
- 7.3.1 Overview
- 7.3.2 Non-Small Cell Lung Cancer (NSCLC): Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
- 7.4.1 Overview
- 7.4.2 Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Lung Cancer Screening Market Analysis - by Technology

8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
- 8.2.1 Overview
- 8.2.2 Low-Dose Computed Tomography (LDCT): Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
- 8.3.1 Overview
- 8.3.2 Chest X-ray: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
- 8.4.1 Overview
- 8.4.2 Liquid Biopsy: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Lung Cancer Screening Market Analysis - by Age Group

9.1 Overview
9.2 & Older
- 9.2.1 Overview
- 9.2.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
- 9.3.1 Overview
- 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Lung Cancer Screening Market Analysis - by End User

10.1 Overview
10.2 Hospitals
- 10.2.1 Overview
- 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2028 - Country Analysis

11.1 Asia Pacific Lung Cancer Screening Market

12. Asia Pacific Lung Cancer Screening Market-Industry Landscape

12.1 Recent Growth Strategies
- 12.1.1 Overview

13. Company Profiles

13.1 Intelerad Medical Systems
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Nuance Communications Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GE HealthCare
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Medtronic
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Canon Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Koninklijke Philips NV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Siemens AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. China: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 2. China: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. Japan: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 6. Japan: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. India: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 10. India: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Australia: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 14. Australia: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. South Korea: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 18. South Korea: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 22. Rest of Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. Recent Growth Strategies in the Asia Pacific Lung Cancer Screening Market
Table 26. Glossary of Terms

List Of Figures

Figure 1. Asia Pacific Lung Cancer Screening Market Segmentation
Figure 2. Asia Pacific Lung Cancer Screening Market, by Country
Figure 3. Asia Pacific Lung Cancer Screening Market Overview
Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Asia Pacific Lung Cancer Screening Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Asia Pacific Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
Figure 10. Asia Pacific Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 11. Non-Small Cell Lung Cancer (NSCLC): Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Asia Pacific Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 14. Low-Dose Computed Tomography (LDCT): Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 15. Chest X-ray: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 16. Liquid Biopsy: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 19. 50 & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 22. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 26. Asia Pacific Lung Cancer Screening Market Revenue Share, by Country, 2022 & 2030 (%)
Figure 27. China: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Japan: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. India: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Australia: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. South Korea: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)